Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. University of Ulsan College of Medicine, Seoul, Korea



Survival: 6.5 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: University of Ulsan College of Medicine
   
Journal: Link
   
Date: 10/2012

Description:
Patients:
This phase 2 study involved 37 advanced urothelial cancer patients who were previously treated with gemcitabine and platinum-based chemotherapy. The median patient age was 57 years and 78% were male.

Treatment:
Patients were treated with a particular formulation of the chemotherapy agent paclitaxel called polymeric micelle formulation.

Toxicities:
The most severe toxicities were of grade 4 and included anemia and infection. Grade 3 nerve disorders and neutropenia were also reported. Grade 1-2 alopecia was reported by 97.1% of patients.

Results:
The median overall survival was 6.5 months.

Support:
The study drug, brand name Genexol-PM, was provided by the manufacturer Samyang Co.

Correspondence: Dr. Jin-Hee Ahn; email: drjiny@amc.seoul.kr

E-mail to a Friend Email Physician More Information